Bristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company is...
Plenty of immunotherapy-based combinations are already vying for share in previously untreated, metastatic kidney cancer, but that’s not stopping Merck and partner Eisai from trying...
WuXi Biologics spent 2020 laying out manufacturing expansions left and right. Now, another CDMO under the WuXi umbrella is getting in on the action. WuXi AppTec subsidiary STA...
For existing PD-1/L1 inhibitors, China represents an opportunity for new growth. But foreign drugmakers have once again lost their chance to reach a wider pool...
As COVID-19 continues to rage around the globe, the FDA’s inspection schedule has fallen into complete shambles—often to the detriment of drugmakers looking to bring...
The COVID-19 pandemic has changed the way the pharmaceutical industry works, crucially in how regulators inspect key manufacturing sites. To skirt around lockdowns, the FDA...
Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the signing of a non-binding Heads of Terms...
Pharma TV advertising spiked in September, even without the usually ubiquitous football media to play it on. The top 10 brands spent $182 million, the highest monthly...
NEW DELHI: Syngene International Ltd on Thursday said it has joined a global consortium of 19 organisations from the healthcare industry to help inform, improve...
NEW DELHI: Syngene International Ltd on Thursday said it has joined a global consortium of 19 organisations from the healthcare industry to help inform, improve...